Abstract: Paracetamol overdosing may cause liver injury including fulminant liver failure due to generation of the toxic metabolites, N-acetyl-p-benzoquinone imine (NAPQI) and p-benzoquinone (p-BQ). Herein, the chelating agent, N,N'-Bis(2-mercaptoethyl)isophthalamide (NBMI), was examined for its potential ability to entrap NAPQI and p-BQ and to prevent paracetamol-induced liver injury. Both NBMI and the conventional paracetamol antidote N-acetylcysteine (NAC) were investigated with regard to their abilities to scavenge the NAPQI and p-BQ in a Transient Receptor Potential Ankyrin 1-dependent screening assay. Stoichiometric evaluations indicated that NBMI was able to entrap these metabolites more efficiently than NAC. Furthermore, oral administration of either NBMI (680 mg/kg) or NAC (680 mg/kg) prevented the development of the characteristic liver necrosis and elevation of serum alanine aminotransferase in a mouse model for paracetamol-induced liver injury. In summary, these results show that NBMI is able to entrap the toxic metabolites NAPQI and p-BQ and to prevent paracetamol-induced liver injury in mice.
Paracetamol is an analgesic and antipyretic drug that, in contrast to non-steroid anti-inflammatory agents, is devoid of gastrointestinal and cardiovascular side effects [1, 2] . However, due to generation of toxic metabolites at higher doses, paracetamol overdosing is the primary cause of acute liver failure in the Western world [3] [4] [5] . The liver toxicity is ascribed to paracetamol's degradation into the electrophilic metabolites NAPQI and p-BQ [6] [7] [8] [9] . Although NAPQI and p-BQ are rapidly detoxified by endogenous glutathione at therapeutic paracetamol doses, higher doses gradually deplete hepatic glutathione stores [10, 11] . Residual NAPQI binds to proteins in hepatocytes, resulting in mitochondrial dysfunction. This increases the levels of oxidative stress-mediated products, which ultimately cause centrilobular necrosis and liver failure [12] .
N-acetylcysteine (NAC) is the standard antidote for paracetamol intoxication [13] . When given within 8-10 hr after paracetamol intake, NAC completely prevents the liver toxic events by replenishing intracellular glutathione, which binds NAPQI but also protects the mitochondrial environment by detoxification of oxidative stress-mediated products [14] . However, start of NAC treatment beyond 8-10 hr dramatically reduces its capacity to prevent liver damage. Moreover, NAC is associated with adverse events, including anaphylactoid reactions with a reported incidence of approximately 20% [15, 16] . N,N'-Bis(2-mercaptoethyl)isophthalamide (NBMI) is a dithiol antioxidant possessing free radicals scavenging capabilities. Its hydrophobic properties enable it to accumulate in the liver, the site of paracetamol's main toxic effects [17] . NBMI is currently investigated in clinical trials for the treatment of mercury poisoning and other indications and appears to be devoid of anaphylactoid-related events [18] [19] [20] .
The current investigation aimed to examine whether NBMI can entrap the electrophilic paracetamol metabolites and prevent paracetamol-induced liver injury.
Materials and Methods
Animals. The study was conducted at Lund University using adult wild-type C57/BL6 mice. Before initiation of experiments, all animals were fed ad libitum in a controlled environment with 12-hr light-dark cycles. All mice were weighed prior to administration of substances for dose adjustments. The experiments were performed in accordance with the European Union directive for the use of animals for scientific purposes (2010/63) and approved by Lund Animal Ethic Committee Drugs. N-acetyl-p-benzoquinone imine (NAPQI) was acquired from Toronto Research Chemicals (North York, ON, Canada), whereas pbenzoquinone (p-BQ), paracetamol, N-acetylcysteine (NAC), Allyl isothiocyanate (AITC) and carboxymethyl cellulose (CMC, medium viscosity) were acquired from Sigma-Aldrich (St. Louis, MO, USA). N,N'-Bis(2-mercaptoethyl)isophthalamide (NBMI) was a gift from EmeraMed Ltd. (Dublin, Ireland). Solutions of all compounds were prepared immediately before usage.
Imaging of intracellular calcium levels. Transient Receptor Potential Ankyrin 1 (TRPA1) is a non-selective cation channel activated by Author for correspondence: Lars Grundemar, Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University, Box 117, S-221 00 Lund, Sweden (e-mail lars.grundemar@med.lu.se). † Deceased electrophilic compounds, including the paracetamol metabolites NAPQI and p-BQ [21] [22] [23] [24] . A TRPA1-dependent screening assay enabled comparisons of TRPA1's responses to NAPQI and p-BQ in the presence and absence of NBMI, permitting evaluation of NBMI's scavenger abilities. Stoichiometric evaluations were designed after consideration of NAPQI's and p-BQ's TRPA1 potency [23] , and limitations regarding NBMI's solubility. In short, human embryonic kidney cells (HEK-293tr) transient expressing human TRPA1 were harvested and distributed onto a Poly-D-lysine (Sigma, St. Louis, MO, USA) treated black 96-well plates (Costar, Cambridge, MA, USA). Cells were exposed to 1 lg/ml tetracycline (Sigma) for 16 hr to induce expression of hTRPA1 before loading with Fura 2-AM (1 or 2 lM) (Invitrogen, Eugene, OR, USA) in the presence of 2 mM probenecid (Sigma) for 1 hr at 37°C. Both loading and experiments were performed in physiological buffer (HEPES) and conducted at 25°C. After exposure to electrophilic paracetamol metabolites and scavengers, cells were consecutively challenged with the TRPA1 agonist AITC (10 lM), which allowed for normalization of activation levels. Alterations in average ratio (340/380 nm) of the Fura-2 fluorescence signal were used as an indicator of hTRPA1 activation and determined every fourth second using ratiometric fluorescents technique, FLIPR (FlexStation 3; Molecular Devices, Sunnyvale, CA, USA). Background noise was removed through subtraction of baseline values to limit the interference from autofluorescence.
Paracetamol-induced liver failure. Adult, male C57/BL6 mice from our own breeding were randomly allocated into one of the treatment groups (8-10 animals in each group). The food source was withdrawn the evening before initiation of experiments (12-16 hr prior to the administration of substances). The dosage of NBMI was limited to 680 mg/kg due to physical constrains, which is about the mid-interval regarding animal studies with NAC (300-1200 mg/kg) [25] . All animals were initially fed with either NBMI (680 mg/kg), NAC (680 mg/kg) or vehicle (0.5% CMC) using a silicon gavage (18G; Fuchigami, Kyoto, Japan) and simultaneously exposed to a sublethal intraperitoneal injection of paracetamol (200 mg/kg). This approach temporally deviates from the clinical setting, but pre-or simultaneous administration of antidote is a commonly used protocol when studying hepatoprotective abilities of substances in rodents [26] [27] [28] [29] . After 24 hr, all animals were briefly anaesthetized with isoflurane and decapitated. The blood was promptly collected in heparin tubes, and the left medial hepatic lobe (lobus hepatis sinister medialis) was excised for further histologic analyses.
Alanine aminotransferase activity. Blood containing heparin tubes were centrifuged at 2000 9 g for 10 min. Serum was collected, and the activity of alanine aminotransferase, a well-characterized hepatic biomarker, was evaluated within 48 hr using Cobas 6000/8000 analyser series (Roche Diagnostics, Rotkreuz, Switzerland).
Histology. The left medial hepatic lobe was excised and fixed in 4% cold formaldehyde in phosphate-buffered saline (PBS) solution for 90 min., subsequently rinsed in PBS supplemented with 15% sucrose. Samples were then frozen in isopentane before sectioning in serial slices of 10 lm thickness by a cryostat (Leica CM3050; Leica microsystems, Wetzlar, Germany). All liver slices were stained with haematoxylin & eosin [(H&E) Sigma]. Nikon Eclipse TE2000-S bright-field microscope (Nikon, Tokyo, Japan) was used to evaluate morphology.
Statistical analyses. The statistical analysis was performed with GraphPad Prism 7.0. (GraphPad Software, La Jolla, CA, USA) utilizing nonparametric Kruskal-Wallis statics followed by Dunn's multiple comparisons test. Data are presented as the mean AE S.E.M., and statistical significance was accepted when p < 0.05. *, **, ***, ****Indicate p < 0.05, 0.01, 0.001 and 0.0001, respectively. Fig. 1 . NBMI and NAC inhibit TRPA1 activation induced by electrophilic paracetamol metabolites. Electrophilic compounds, including the liver toxic paracetamol metabolites N-acetyl-p-benzoquinone imine (NAPQI) and p-benzoquinone (p-BQ), activate human Transient Receptor Potential Ankyrin 1 channels. Activation mediated by NAPQI (A) and p-BQ (B) was countered by N,N'-Bis(2-mercaptoethyl)isophthalamide (NBMI) and N-acetylcysteine (NAC). Graphs display mean AE S.E.M., n = 6-9.
Results
Effects of NBMI and NAC on NAPQI-and p-BQ-mediated hTRPA1 activation. NAC and NBMI have previously been identified as scavengers for reactive oxygen species (ROS) in vitro [17, 30] . In this study, both NBMI and NAC were able entrap the electrophilic paracetamol metabolites NAPQI and p-BQ as reflected by their ability to block hTRPA1 activation ( fig. 1A,  B) . Furthermore, stoichiometric evaluation revealed that NBMI had a higher capacity than NAC to counter electrophilic hTRPA1 activation, corresponding to a 2:1 (NAPQI:NBMI) binding ratio. These data are further supported by LS-MS/MS methods ( Figure S1 ), and similar trends are also apparent for p-BQ (fig. 1B) .
Effects of NBMI and NAC in paracetamol-induced liver injury. NBMI was evaluated in a mouse model for the possible prevention of paracetamol-induced liver injury. Intraperitoneal injection of paracetamol (200 mg/kg) resulted in an expected liver injury characterized by centrilobular necrosis that was evident after 24 hr ( fig. 2A) . In contrast, the liver tissue from animals who had simultaneously received NBMI (680 mg/kg, p.o.) or NAC (680 mg/kg, p.o.) appeared normal upon histologic examination ( fig. 2B,C) . NBMI and NAC were also able to prevent paracetamol-induced elevation of serum alanine aminotransferase (ALT) (fig. 2D ).
Discussion
Herein, we show that NBMI was able to bind electrophilic paracetamol metabolites and to prevent the characteristic liver injury produced by extensive paracetamol dosage in mice.
NAPQI has been identified as the main metabolite responsible for paracetamol's liver toxicity. Although less characterized than NAPQI, p-BQ may also contribute in the hepatotoxic process by consumption of protective glutathione [7] . In the present study, we utilized TRPA1's electrophilic sensor abilities to demonstrate that both NBMI and NAC were able to entrap NAPQI and p-BQ as a reflection of their scavenging properties. Furthermore, stoichiometric evaluations and LS-MS/MS analyses indicated that NBMI possessed a higher scavenger capacity than NAC, which can be explained by NBMI's two thiol groups. NBMI and NAC were also evaluated in a mice model for paracetamol-induced liver injury. NBMI and NAC were independently able to inhibit paracetamol-induced ALT elevations. Post-mortem morphologic evaluation revealed that while paracetamol induced the characteristic centrilobular liver necrosis, there were no apparent histological changes observed in animals co-treated with either NBMI or NAC. However, whereas NAC completely prevented the ALT elevation, there remained a minor increase in serum ALT activity in animals treated with NBMI. It is noteworthy that the higher efficacy of NBMI to entrap NAPQI and p-BQ compared to NAC in vitro did not translate into higher preventing effect in the mouse. This result may be a consequence from the inability of the TRPA1-mediated screening model to capture the effects from in vivo biotransformation of NAC into glutathione. Nonetheless, as indicated by the TRPA1-mediated screening, NBMI was able to prevent hepatotoxicity in mice, and this cell-based assay may therefore represent a tentative model for in vitro identification of putative paracetamol antidotes and evaluation of their scavenge potential. NAPQI enhances the formation of ROS by disruption of mitochondrial activities in hepatocytes. This is an important mechanism in the aetiology of paracetamol-induced liver failure and states the therapeutic potential of intracellular antioxidants [12, 31] . Interestingly, NBMI is known to cross cellular membranes and accumulate in the liver, the site where ROS and NAPQI are predominantly produced during paracetamol overdosing. Metabolic profiling with human liver microsomes has indicated that NBMI acts as a highly efficient scavenger of hydroxyl-free radicals as each thiol group can interact and stabilize several radical oxygens [17] . Thus, in vitro data suggest that NBMI is able to entrap electrophilic paracetamol metabolites, which initiate the hepatotoxic process, and to efficiently bind oxidative stress-mediated products responsible for the progression and generation of paracetamol-induced liver injury.
In summary, we suggest that TRPA1-mediated screening is a useful in vitro assay to evaluate the entrapment of the toxic paracetamol metabolites NAPQI and p-BQ by putative paracetamol antidotes. Similar to NAC, NBMI was shown to be an efficient scavenger of electrophilic paracetamol metabolites and able to prevent paracetamol-induced liver injury in mice. Additional studies are needed to evaluate whether NBMI given i.v. can be tested as a potential antidote to paracetamol intoxication in human beings.
